XML Print


1- Department of Biology, Faculty of Science, Payame Noor University, Tehran, Iran
2- Department of Biochemistry
3- Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran
4- Cardiovascular Department, Modares Hospital, Tehran, Iran
5- Department of Biochemistry, Islamic Azad University of Central Tehran Branch, Tehran, Iran
6- Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran. , reza_saghiri@yahoo.com
Abstract:   (1392 Views)
Background: Although several clinical and laboratory diagnostic approaches have been developed for Coronary Artery Disease (CAD), rates of mortality and morbidity have remained high, which may be due to defective diagnostic markers. Here, we evaluated the serum levels of selected trace elements (Zn, Se, and Cu) in CAD patients and healthy subjects and assessed their diagnostic values in CAD.
Methods: 53 cardiologist-approved CAD patients and 48 age and sex-matched healthy controls were recruited. The serum levels of Zn, Se, and Cu, were assessed using the atomic absorption method. GraphPad v.8.4 and SPSS v.18 software were used for statistical analyses.
Results: The serum levels of Zn and Se were significantly lower in the CAD patients than in controls (P = 0.0008 and P < 0.0001, respectively). In contrast, CAD patients showed significantly higher levels of Cu (P = 0.0064). Concerning the ROC curve analyses, the area under the curve (AUC) for Zn was 0.6563 (P = 0.0069). Setting the cut-off value at 1.255 μg/mL gave a sensitivity of 56.60%, specificity of 66.67%, and likelihood ratio (LR) of 1.698. AUC for Se was 0.8595 (P<0.0001). The optimum cut-off value at 86.50 ng/ml level gave a sensitivity of 83.02%, specificity of 75.00%, and LR of 3.321. The AUC for Cu was 0.6557 (P = 0.0071). The optimum cut-off value at 1.225 μg/mL level gave a sensitivity of 62.26%, specificity of 64.58%, and LR of 1.758.
Conclusion: Our study showed that selenium can be a biomarker with reliable diagnostic value for CAD.

Full-Text [PDF 446 kb]   (346 Downloads)    
Research Article: Original Paper | Subject: Biochemistry
Received: 2024/01/5 | Accepted: 2025/02/23

References
1. Ghassibe-Sabbagh M, Platt DE, Youhanna S, Abchee AB, Stewart K, Badro DA, et al. Genetic and environmental influences on total plasma homocysteine and its role in coronary artery disease risk. Atherosclerosis. 2012;222(1):180-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Cassar A, Holmes Jr DR, Rihal CS, Gersh BJ, editors. Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc. 2009;84(12):1130-46. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M. Biomarkers for the diagnosis and management of heart failure. Heart Fail Rev. 2022;27(2):625-43. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Rovira J, Hernández-Aguilera A, Luciano-Mateo F, Cabré N, Baiges-Gaya G, Nadal M, et al. Trace elements and paraoxonase-1 activity in lower extremity artery disease. Biol Trace Elem Res. 2018;186(1):74-84. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Bhattacharya PT, Misra SR, Hussain M. Nutritional aspects of essential trace elements in oral health and disease: an extensive review. Scientifica. 2016:2016:5464373. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Mehri A. Trace elements in human nutrition (ii)-an update. Int J Prev Med. 2020:11:2. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Cebi A, Kaya Y, Gungor H, Demir H, Yoruk IH, Soylemez N, et al. Trace elements, heavy metals and vitamin levels in patients with coronary artery disease. Int J Med Sci. 2011;8(6):456-60. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Noshin TF, Ali MR, Banik S. Increased oxidative stress and altered serum macro-minerals and trace elements levels are associated with coronary artery disease. J Trace Elem Med Biol. 2021;64:126707. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Ekpenyong CE. Essential trace element and mineral deficiencies and cardiovascular diseases: facts and controversies. Int J Food Sci Nutr. 2017;6(2):53-64. [View at Publisher] [DOI]
10. Ghayour-Mobarhan M, Taylor A, Kazemi-Bajestani SMR, Lanham-New S, Lamb DJ, Vaidya N, et al. Serum zinc and copper status in dyslipidaemic patients with and without established coronary artery disease. Clin Lab. 2008;54(9-10):321-9. [View at Publisher] [DOI] [Google Scholar]
11. Goodyear MD, Krleza-Jeric K, Lemmens T. The declaration of Helsinki. BMJ. 2007;335(7621):624-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Head SJ, Howell NJ, Osnabrugge RL, Bridgewater B, Keogh BE, Kinsman R, et al. The European association for cardio-thoracic surgery (EACTS) database: An introduction. Eur J Cardiothorac Surg. 2013;44(3):e175-e80. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Association EHR, Surgery EAfC-T, Camm AJ, Kirchhof P, Lip GY, Schotten U, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-429. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Bauersachs R, Zeymer U, Brière J-B, Marre C, Bowrin K, Huelsebeck M. Burden of coronary artery disease and peripheral artery disease: a literature review. Cardiovascular therapeutics. 2019;2019. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Kazemi-Bajestani SMR, Ghayour-Mobarhan M, Ebrahimi M, Moohebati M, Esmaeili HA, Parizadeh MR, et al. Serum copper and zinc concentrations are lower in Iranian patients with angiographically defined coronary artery disease than in subjects with a normal angiogram. J Trace Elem Med Biol. 2007;21(1):22-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Kosar F, Taskapan C, Kucukbay Z. Serum levels of selenium, zinc and copper in patients with coronary artery ectasia. Indian Heart J. 2007;59(1):3841. [View at Publisher] [PMID] [Google Scholar]
17. Little PJ, Bhattacharya R, Moreyra AE, Korichneva IL. Zinc and cardiovascular disease. Nutrition. 2010;26(11-12):1050-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Schnabel R, Lubos E, Messow CM, Sinning CR, Zeller T, Wild PS, et al. Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease: The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. Am Heart J. 2008;156(6):1201.e1-.e11. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Hassanzadeh M, Faridhosseini R, Mahini M, Faridhosseini F, Ranjbar A. Serum levels of TNF-a, IL-6, and selenium in patients with acute and chronic coronary artery disease. Iran J Immunol. 2006;3(3):142-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Parizadeh SMR, Moohebati M, Ghafoori F, Ghayour-Mobarhan M, Kazemi-Bajestani SMR, Tavallaie S, et al. Serum selenium and glutathione peroxidase concentrations in Iranian patients with angiography-defined coronary artery disease. Angiology. 2009;60(2):186-91. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Ilyas A, Shah MH. Abnormalities of Selected Trace Elements in Patients with Coronary Artery Disease. Acta Cardiol Sin. 2015;31(6):518-27. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Pan M, Cheng Z-W, Huang C-G, Ye Z-Q, Sun L-J, Chen H, et al. Long-term exposure to copper induces mitochondria-mediated apoptosis in mouse hearts. Ecotoxicol Environ Saf. 2022;234:113329. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Hackler J, Wisniewska M, Greifenstein-Wiehe L, Minich WB, Cremer M, Bührer C, et al. Copper and selenium status as biomarkers of neonatal infections. J Trace Elem Med Biol. 2020;58:126437. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Zhao Y, Sun Q, Zhang X, Baeyens J, Su H. Self-assembled selenium nanoparticles and their application in the rapid diagnostic detection of small cell lung cancer biomarkers. Soft Matter. 2018;14(4):481-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Sun Q, Hackler J, Hilger J, Gluschke H, Muric A, Simmons S, et al. Selenium and copper as biomarkers for pulmonary arterial hypertension in systemic sclerosis. Nutrients. 2020;12(6):1894. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Knez M, Glibetic M. Zinc as a Biomarker of Cardiovascular Health. Front Nutr. 2021:8:686078. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Choi S, Liu X, Pan Z. Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases. Acta Pharmacol Sin. 2018;39(7):1120-32. [View at Publisher] [DOI] [PMID] [Google Scholar]
28. Faber S, Zinn GM, Kern 2nd JC, Skip Kingston HM. The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers. 2009;14(3):171-80. [View at Publisher] [DOI] [PMID] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.